Lack of liver steatosis in germ-free mice following hypercaloric diets.
Fructose
Germ free
Intestinal barrier
Liver steatosis
Mucin
Western-style diet
Journal
European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
30
11
2017
accepted:
08
06
2018
pubmed:
22
6
2018
medline:
31
1
2020
entrez:
22
6
2018
Statut:
ppublish
Résumé
Experimental liver steatosis induced by overfeeding is associated with enhanced gut permeability and endotoxin translocation to the liver. We examined the role of the gut microbiota for steatosis formation by performing the feeding experiments in mice raised under conventional and germ-free (GF) housing. Adult wild-type and GF mice were fed a Western-style diet (WSD) or a control diet (CD), the latter combined with liquid fructose supplementation (F) or not, for 8 weeks. Markers of liver steatosis and gut permeability were measured after intervention. Mice fed a WSD increased body weight compared to those fed a CD (p < 0.01) under conventional, but not under GF conditions. Increased liver weight, liver-to-body-weight ratio and hepatic triglycerides observed in both the WSD and the CD + F groups, when compared with the CD group, were not apparent under GF conditions, whereas elevated plasma triglycerides were visible (p < 0.05). Wild-type mice fed a WSD or a CD + F, respectively, had thinner adherent mucus layer compared to those fed a CD (p < 0.01), whereas GF mice had always a thin mucus layer independently of the diet. GF mice fed a CD showed increased plasma levels of FITC-dextran 4000 (1.9-fold, p < 0.05) and intestinal fatty acid-binding protein-2 (2.4-fold, p < 0.05) compared with wild-type mice. GF housing results in an impaired weight gain and a lack of steatosis following a WSD. Also the fructose-induced steatosis, which is unrelated to body weight changes, is absent in GF mice. Thus, diet-induced experimental liver steatosis depends in multiple ways on intestinal bacteria.
Identifiants
pubmed: 29926176
doi: 10.1007/s00394-018-1748-4
pii: 10.1007/s00394-018-1748-4
doi:
Substances chimiques
Fructose
30237-26-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1933-1945Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : BI 424/8-1
Références
J Gastroenterol. 1999 Feb;34(1):54-60
pubmed: 10204611
Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15718-23
pubmed: 15505215
J Histochem Cytochem. 2007 May;55(5):505-13
pubmed: 17242463
J Immunol. 2007 Sep 1;179(5):3109-18
pubmed: 17709525
J Hepatol. 2008 Jun;48(6):983-92
pubmed: 18395289
Hepatology. 2009 Oct;50(4):1094-104
pubmed: 19637282
Diabetes Obes Metab. 2010 Oct;12 Suppl 2:83-92
pubmed: 21029304
J Hepatol. 2011 Jun;54(6):1090-3
pubmed: 21281684
J Inflamm (Lond). 2011 Mar 16;8:8
pubmed: 21410952
Commun Agric Appl Biol Sci. 2011;76(1):53-6
pubmed: 21539196
Cell Mol Life Sci. 2011 Nov;68(22):3635-41
pubmed: 21947475
Appl Environ Microbiol. 1990 Jun;56(6):1919-25
pubmed: 2200342
Methods Mol Biol. 2012;842:229-35
pubmed: 22259139
Gastroenterology. 2012 Apr;142(4):711-725.e6
pubmed: 22326434
Lab Invest. 2012 Jul;92(7):1020-32
pubmed: 22525431
Nature. 2012 Sep 13;489(7415):242-9
pubmed: 22972297
Benef Microbes. 2014 Mar;5(1):3-17
pubmed: 23886976
Science. 2013 Sep 6;341(6150):1241214
pubmed: 24009397
J Nutr Biochem. 2014 Feb;25(2):118-25
pubmed: 24445036
Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10
pubmed: 24731669
Gut. 2014 Sep;63(9):1513-21
pubmed: 24833634
Dig Dis Sci. 2016 Mar;61(3):737-46
pubmed: 26520109
Gut. 2017 Apr;66(4):620-632
pubmed: 27196572
N Engl J Med. 2016 Dec 15;375(24):2369-2379
pubmed: 27974040
Am J Clin Nutr. 2017 Jan;105(1):127-135
pubmed: 28049662
J Nutr. 2017 May;147(5):770-780
pubmed: 28356436
Bacteriol Rev. 1971 Dec;35(4):390-429
pubmed: 4945725
Acta Pathol Microbiol Immunol Scand B. 1984 Oct;92(5):247-52
pubmed: 6516849